1. Home
  2. FTCI vs GNLX Comparison

FTCI vs GNLX Comparison

Compare FTCI & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FTC Solar Inc.

FTCI

FTC Solar Inc.

HOLD

Current Price

$2.36

Market Cap

122.4M

Sector

Technology

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.54

Market Cap

110.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTCI
GNLX
Founded
2017
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.4M
110.4M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
FTCI
GNLX
Price
$2.36
$2.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$10.80
$17.25
AVG Volume (30 Days)
273.5K
307.9K
Earning Date
05-01-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.47
EPS
N/A
N/A
Revenue
$99,687,000.00
$8,000.00
Revenue This Year
$65.44
N/A
Revenue Next Year
$45.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
110.51
N/A
52 Week Low
$1.99
$2.29
52 Week High
$12.75
$8.54

Technical Indicators

Market Signals
Indicator
FTCI
GNLX
Relative Strength Index (RSI) 42.60 42.93
Support Level $1.99 $2.51
Resistance Level $2.90 $2.95
Average True Range (ATR) 0.22 0.15
MACD 0.08 -0.01
Stochastic Oscillator 42.08 28.57

Price Performance

Historical Comparison
FTCI
GNLX

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: